LINICAL Europe
LINICAL Europe is recorded as a service provider in 6 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 6 of 6 trials · Latest update first
An Open-label, Multicentre, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VaboremⓇ (Meropenem-Vaborbactam) in Paediatric Population with suspected or confirmed Gram negative infections, including but not restricted to Complicated Urinary Tract Infections.
Sponsor Menarini Ricerche S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Single Group Treatment, Phase 2 study to investigate Pharmacokinetics, Safety and Tolerability of Cefepime-Enmetazobactam administered by intra-venous infusion over 2 hours in Male or Female Participants from birth to less than 18 years of age hospitalized with complicated urinary tract infections (cUTI) including Acute Pyelonephritis (AP).
Sponsor Orchid Pharma Europe GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicenter phase 1/2 dose-finding and dose expansion study of OSE-279, a PD-1 blocking monoclonal antibody, in subjects with advanced solid tumors or lymphomas
Sponsor OSE Immunotherapeutics
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2a, Randomized, Placebo-Controlled, Double Blind Multiple Ascending Dose Study in Patients with Cystic Fibrosis Carrying the 3849 +10 Kb C->T Mutation to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84
Sponsor Splisense Ltd.
- Start (EU)
- Latest update
- Estimated end
An open label study followed by a randomised, double-blind, placebo-controlled, parallel group and an extension study to investigate the safety and efficacy of GB1211 (a galectin-3 inhibitor) in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSCLC).
Sponsor Galecto Biotech AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
An open-label, multicenter, phase 1b/2 study of E7386 in combination with pembrolizumab in previously treated subjects with selected solid tumors
Sponsor Eisai Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for LINICAL Europe?
The 2026-10-09 snapshot links LINICAL Europe to 6 distinct CTIS trials. Recorded services include Clinical monitoring, Project management, Investigator recruitment, Regulatory services, among 17 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for LINICAL Europe?
The most frequently recorded therapeutic areas are Infectious Disease, Genetic and Congenital Disorders, Haematological Malignancies, Respiratory. Recorded phases include Phase 2, Phase 1. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to LINICAL Europe conducted?
The linked trials record locations in 12 countries, including Spain, France, Czechia, Poland, Hungary. These are trial locations, not confirmed office locations or countries where LINICAL Europe delivered services.
What can this page tell me about LINICAL Europe's trial experience?
Browse 6 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under LINICAL Europe. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- LINICAL Europe GmbH